HANOI — Vietnam has become the first country in the world to grant official approval to Pembroria (also reported as Pembrolia), a Russian-developed cancer treatment that officials in Moscow have described as a “cancer vaccine.” The decision, announced by the Ministry of Health in late October, marks a significant step in Southeast Asia’s access to advanced immunotherapy and underscores Hanoi’s deepening medical cooperation with Moscow. The drug, produced by Russia’s Limited Liability Company PK-137 and registered through a facility in the United Arab Emirates, contains 100 milligrams of pembrolizumab per 4 millilitres and is formulated for intravenous infusion. With a … Continue reading Vietnam Becomes First Nation to Approve Russia’s Cancer Drug, Opening New Front in Global Oncology